Verteporfin has been evaluated in clinical trials of various cancer types, including cutaneous metastatic breast cancer, and in vitro and in vivo experiments in human glioblastoma stem cells and xenograft models identified verteporfin as a therapeutic candidate in EGFR-variant glioblastoma [58]. The gene discussed is EGFR; the disease is cancer.